Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers
Date published
Schizophrenia - 10.08.2019
Read time: 1 min
Share this
The benefits of long-acting injectable antipsychotic treatment for patients with schizophrenia should be discussed with both patients and their families. Professor John Kane and Doctor Charlotte Emborg explain their perspectives.
We have just sent you an email, with a confirmation link. Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.